Task: Answer the multiple-choice question.
Question: Which drug exhibits a 17.652% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) COc1ccccc1Cn1c(=S)[nH]c2ccc(Br)cc2c1=O
b) CO/N=C/NC(=O)NOCc1ccc(Cl)cc1Cl
Answer: a. COc1ccccc1Cn1c(=S)[nH]c2ccc(Br)cc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1Cn1c(=S)[nH]c2ccc(Br)cc2c1=O
COc1ccccc1Cn1c(=S)[nH]c2ccc(Br)cc2c1=O
6-bromo-3-[(2-methoxyphenyl)methyl]-2-sulfanylidene-1H-quinazolin-4-one